Maravai LifeSciences (MRVI)
(Delayed Data from NSDQ)
$8.44 USD
-0.40 (-4.52%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $8.44 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Brokerage Reports
0 items in cart
Maravai LifeSciences Holdings, Inc. [MRVI]
Reports for Purchase
Showing records 21 - 40 ( 72 total )
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
3Q22 - Less Pfizer Makes Maravai More Compelling
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Appointment of Trey Martin, CEO Is Precursor to Very Different Business Profile in 2024
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Life Sciences: COVID Era Concluding - Mapping Company Exposure
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Pfizer Guidance Brings FY23-FY24 into Focus
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
DHR & SRT3: Strong Life Science Earnings Season Begins
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
2Q Preview - Mapping COVID Sales; 2023 Visibility Increasing
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Undervalued mRNA Tools Company -1Q Exceeds
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Sartorius Bidding for Maravai? An Illumina or Aldevron Outcome?
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Raises Guide; Ex-COVID Light but Clear Momentum
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Life Science Tools: A Pivotal Upcoming Week Providing Key 2022 Read-Throughs for the Sector
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Maravai LifeSciences Holdings, Inc.
Industry: Medical - Products
Goldilocks Ignored - JPM Week and Implications for Coverage List
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department